488 related articles for article (PubMed ID: 30671777)
1. The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer's disease.
Rubin LH; Sundermann EE; Moore DJ
J Neurovirol; 2019 Oct; 25(5):661-672. PubMed ID: 30671777
[TBL] [Abstract][Full Text] [Related]
2. Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer's disease?
Fulop T; Witkowski JM; Larbi A; Khalil A; Herbein G; Frost EH
J Neurovirol; 2019 Oct; 25(5):634-647. PubMed ID: 30868421
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal brain atrophy patterns and neuropsychological performance in older adults with HIV-associated neurocognitive disorder compared with early Alzheimer's disease.
Milanini B; Samboju V; Cobigo Y; Paul R; Javandel S; Hellmuth J; Allen I; Miller B; Valcour V
Neurobiol Aging; 2019 Oct; 82():69-76. PubMed ID: 31425903
[TBL] [Abstract][Full Text] [Related]
4. APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - a cross-sectional observational study.
Cysique LA; Hewitt T; Croitoru-Lamoury J; Taddei K; Martins RN; Chew CS; Davies NN; Price P; Brew BJ
BMC Neurol; 2015 Apr; 15():51. PubMed ID: 25880550
[TBL] [Abstract][Full Text] [Related]
5. Aging, comorbidities, and the importance of finding biomarkers for HIV-associated neurocognitive disorders.
Rosenthal J; Tyor W
J Neurovirol; 2019 Oct; 25(5):673-685. PubMed ID: 30868422
[TBL] [Abstract][Full Text] [Related]
6. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
[TBL] [Abstract][Full Text] [Related]
7. Beta amyloid levels in cerebrospinal fluid of HIV-infected people vary by exposure to antiretroviral therapy.
Fields JA; Swinton MK; Soontornniyomkij B; Carson A; Achim CL
AIDS; 2020 Jun; 34(7):1001-1007. PubMed ID: 32073451
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of age-related HIV neurodegeneration.
Mackiewicz MM; Overk C; Achim CL; Masliah E
J Neurovirol; 2019 Oct; 25(5):622-633. PubMed ID: 30790184
[TBL] [Abstract][Full Text] [Related]
9. Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigm.
Cysique LA; Brew BJ
J Neurovirol; 2019 Oct; 25(5):710-721. PubMed ID: 30635846
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic biomarkers for HAND.
McLaurin KA; Booze RM; Mactutus CF
J Neurovirol; 2019 Oct; 25(5):686-701. PubMed ID: 30607890
[TBL] [Abstract][Full Text] [Related]
11. Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database.
Ben Bouallègue F; Mariano-Goulart D; Payoux P;
Alzheimers Res Ther; 2017 Apr; 9(1):32. PubMed ID: 28441967
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) in Alzheimer's disease and HIV-1 associated neurocognitive disorders.
Garces A; Martinez B; De La Garza R; Roy D; Vallee KA; Fields JA; Moore DJ; Rodrigo H; Roy U
Sci Rep; 2023 Feb; 13(1):3276. PubMed ID: 36841839
[TBL] [Abstract][Full Text] [Related]
13. Differentiating HIV-Associated Neurocognitive Disorders From Alzheimer's Disease: an Emerging Issue in Geriatric NeuroHIV.
Milanini B; Valcour V
Curr HIV/AIDS Rep; 2017 Aug; 14(4):123-132. PubMed ID: 28779301
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's Disease Pathology in Middle Aged and Older People with HIV: Comparisons with Non-HIV Controls on a Healthy Aging and Alzheimer's Disease Trajectory and Relationships with Cognitive Function.
Sundermann EE; Campbell LM; Villers O; Bondi MW; Gouaux B; Salmon DP; Galasko D; Soontornniyomkij V; Ellis RJ; Moore DJ
Viruses; 2023 Jun; 15(6):. PubMed ID: 37376619
[TBL] [Abstract][Full Text] [Related]
15. A Decade of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Belgium.
Somers C; Struyfs H; Goossens J; Niemantsverdriet E; Luyckx J; De Roeck N; De Roeck E; De Vil B; Cras P; Martin JJ; De Deyn PP; Bjerke M; Engelborghs S
J Alzheimers Dis; 2016 Aug; 54(1):383-95. PubMed ID: 27567807
[TBL] [Abstract][Full Text] [Related]
16. The comorbidity of HIV-associated neurocognitive disorders and Alzheimer's disease: a foreseeable medical challenge in post-HAART era.
Xu J; Ikezu T
J Neuroimmune Pharmacol; 2009 Jun; 4(2):200-12. PubMed ID: 19016329
[TBL] [Abstract][Full Text] [Related]
17. Cognitive impairment in HIV infection is associated with MRI and CSF pattern of neurodegeneration.
Steinbrink F; Evers S; Buerke B; Young P; Arendt G; Koutsilieri E; Reichelt D; Lohmann H; Husstedt IW;
Eur J Neurol; 2013 Mar; 20(3):420-428. PubMed ID: 23095123
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychological Decline Improves Prediction of Dementia Beyond Alzheimer's Disease Biomarker and Mild Cognitive Impairment Diagnoses.
Nation DA; Ho JK; Dutt S; Han SD; Lai MHC;
J Alzheimers Dis; 2019; 69(4):1171-1182. PubMed ID: 31104015
[TBL] [Abstract][Full Text] [Related]
19. New developments in the diagnosis of dementia.
Eschweiler GW; Leyhe T; Klöppel S; Hüll M
Dtsch Arztebl Int; 2010 Oct; 107(39):677-83. PubMed ID: 20963198
[TBL] [Abstract][Full Text] [Related]
20. The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease.
Hohman TJ; Bell SP; Jefferson AL;
JAMA Neurol; 2015 May; 72(5):520-9. PubMed ID: 25751166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
